nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—osteoarthritis—Prednisone—systemic scleroderma	0.373	1	CpDpCtD
Ibuprofen—UGT1A9—Mycophenolic acid—systemic scleroderma	0.0539	0.134	CbGbCtD
Ibuprofen—UGT2B7—Mycophenolic acid—systemic scleroderma	0.051	0.126	CbGbCtD
Ibuprofen—UGT1A1—Mycophenolic acid—systemic scleroderma	0.0441	0.109	CbGbCtD
Ibuprofen—UGT1A9—Mycophenolate mofetil—systemic scleroderma	0.0301	0.0746	CbGbCtD
Ibuprofen—UGT2B7—Mycophenolate mofetil—systemic scleroderma	0.0285	0.0706	CbGbCtD
Ibuprofen—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.0246	0.061	CbGbCtD
Ibuprofen—CYP2C8—Mometasone—systemic scleroderma	0.0181	0.0449	CbGbCtD
Ibuprofen—SLCO1A2—Prednisone—systemic scleroderma	0.0145	0.0358	CbGbCtD
Ibuprofen—SLC22A6—Captopril—systemic scleroderma	0.0139	0.0345	CbGbCtD
Ibuprofen—ALB—Captopril—systemic scleroderma	0.0119	0.0294	CbGbCtD
Ibuprofen—SLC22A11—Methotrexate—systemic scleroderma	0.0109	0.0269	CbGbCtD
Ibuprofen—ABCC4—Methotrexate—systemic scleroderma	0.0101	0.025	CbGbCtD
Ibuprofen—ALB—Mycophenolate mofetil—systemic scleroderma	0.00934	0.0231	CbGbCtD
Ibuprofen—ABCB1—Lisinopril—systemic scleroderma	0.00829	0.0205	CbGbCtD
Ibuprofen—CYP2C9—Leflunomide—systemic scleroderma	0.00815	0.0202	CbGbCtD
Ibuprofen—ABCC1—Methotrexate—systemic scleroderma	0.00812	0.0201	CbGbCtD
Ibuprofen—ALB—Prednisone—systemic scleroderma	0.00747	0.0185	CbGbCtD
Ibuprofen—SLCO1A2—Methotrexate—systemic scleroderma	0.00725	0.018	CbGbCtD
Ibuprofen—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.00722	0.0179	CbGbCtD
Ibuprofen—SLC22A8—Methotrexate—systemic scleroderma	0.00631	0.0156	CbGbCtD
Ibuprofen—ABCB1—Captopril—systemic scleroderma	0.00621	0.0154	CbGbCtD
Ibuprofen—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.00489	0.0121	CbGbCtD
Ibuprofen—CYP2C19—Prednisone—systemic scleroderma	0.00484	0.012	CbGbCtD
Ibuprofen—SLC22A6—Methotrexate—systemic scleroderma	0.0044	0.0109	CbGbCtD
Ibuprofen—CYP2C9—cardial valve—systemic scleroderma	0.00407	0.0881	CbGeAlD
Ibuprofen—ABCB1—Prednisone—systemic scleroderma	0.00391	0.00967	CbGbCtD
Ibuprofen—ALB—Methotrexate—systemic scleroderma	0.00375	0.00928	CbGbCtD
Ibuprofen—THBD—artery—systemic scleroderma	0.00308	0.0667	CbGeAlD
Ibuprofen—PPARG—dermis—systemic scleroderma	0.00288	0.0624	CbGeAlD
Ibuprofen—THBD—endothelium—systemic scleroderma	0.0026	0.0563	CbGeAlD
Ibuprofen—THBD—blood vessel—systemic scleroderma	0.0024	0.0519	CbGeAlD
Ibuprofen—ABCB1—Methotrexate—systemic scleroderma	0.00196	0.00485	CbGbCtD
Ibuprofen—FABP2—digestive system—systemic scleroderma	0.00139	0.0301	CbGeAlD
Ibuprofen—PTGS2—skeletal joint—systemic scleroderma	0.00127	0.0275	CbGeAlD
Ibuprofen—THBD—smooth muscle tissue—systemic scleroderma	0.00112	0.0244	CbGeAlD
Ibuprofen—THBD—skin of body—systemic scleroderma	0.00111	0.024	CbGeAlD
Ibuprofen—PPARG—artery—systemic scleroderma	0.00104	0.0226	CbGeAlD
Ibuprofen—THBD—digestive system—systemic scleroderma	0.000888	0.0192	CbGeAlD
Ibuprofen—PPARG—endothelium—systemic scleroderma	0.00088	0.0191	CbGeAlD
Ibuprofen—BCL2—connective tissue—systemic scleroderma	0.000866	0.0188	CbGeAlD
Ibuprofen—UGT1A3—digestive system—systemic scleroderma	0.000858	0.0186	CbGeAlD
Ibuprofen—THBD—tendon—systemic scleroderma	0.000845	0.0183	CbGeAlD
Ibuprofen—PPARG—blood vessel—systemic scleroderma	0.000812	0.0176	CbGeAlD
Ibuprofen—BCL2—smooth muscle tissue—systemic scleroderma	0.000792	0.0172	CbGeAlD
Ibuprofen—BCL2—skin of body—systemic scleroderma	0.000782	0.0169	CbGeAlD
Ibuprofen—UGT2B4—lung—systemic scleroderma	0.000747	0.0162	CbGeAlD
Ibuprofen—THBD—lung—systemic scleroderma	0.000742	0.0161	CbGeAlD
Ibuprofen—CXCL8—smooth muscle tissue—systemic scleroderma	0.000734	0.0159	CbGeAlD
Ibuprofen—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.000703	0.624	CbGdCrCtD
Ibuprofen—CFTR—digestive system—systemic scleroderma	0.000633	0.0137	CbGeAlD
Ibuprofen—BCL2—digestive system—systemic scleroderma	0.000626	0.0135	CbGeAlD
Ibuprofen—UGT1A9—digestive system—systemic scleroderma	0.000611	0.0132	CbGeAlD
Ibuprofen—PLAT—tendon—systemic scleroderma	0.000595	0.0129	CbGeAlD
Ibuprofen—PTGS1—artery—systemic scleroderma	0.000557	0.0121	CbGeAlD
Ibuprofen—PTGS2—artery—systemic scleroderma	0.000532	0.0115	CbGeAlD
Ibuprofen—CFTR—lung—systemic scleroderma	0.000529	0.0115	CbGeAlD
Ibuprofen—PLAT—lung—systemic scleroderma	0.000522	0.0113	CbGeAlD
Ibuprofen—BCL2—lung—systemic scleroderma	0.000522	0.0113	CbGeAlD
Ibuprofen—UGT2B7—digestive system—systemic scleroderma	0.000493	0.0107	CbGeAlD
Ibuprofen—CXCL8—lung—systemic scleroderma	0.000484	0.0105	CbGeAlD
Ibuprofen—SLC22A11—digestive system—systemic scleroderma	0.00048	0.0104	CbGeAlD
Ibuprofen—PTGS1—endothelium—systemic scleroderma	0.000471	0.0102	CbGeAlD
Ibuprofen—PTGS2—endothelium—systemic scleroderma	0.00045	0.00974	CbGeAlD
Ibuprofen—PTGS1—blood vessel—systemic scleroderma	0.000434	0.0094	CbGeAlD
Ibuprofen—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000424	0.376	CbGdCrCtD
Ibuprofen—UGT1A1—digestive system—systemic scleroderma	0.000419	0.00907	CbGeAlD
Ibuprofen—PPARG—connective tissue—systemic scleroderma	0.000416	0.00901	CbGeAlD
Ibuprofen—PTGS2—blood vessel—systemic scleroderma	0.000415	0.00898	CbGeAlD
Ibuprofen—PPARG—smooth muscle tissue—systemic scleroderma	0.000381	0.00824	CbGeAlD
Ibuprofen—PPARG—skin of body—systemic scleroderma	0.000376	0.00814	CbGeAlD
Ibuprofen—SLCO2B1—digestive system—systemic scleroderma	0.000308	0.00667	CbGeAlD
Ibuprofen—PPARG—digestive system—systemic scleroderma	0.000301	0.00651	CbGeAlD
Ibuprofen—SLCO2B1—tendon—systemic scleroderma	0.000293	0.00635	CbGeAlD
Ibuprofen—PPARG—tendon—systemic scleroderma	0.000286	0.00619	CbGeAlD
Ibuprofen—SLCO1A2—digestive system—systemic scleroderma	0.000284	0.00614	CbGeAlD
Ibuprofen—ABCC4—digestive system—systemic scleroderma	0.000273	0.00591	CbGeAlD
Ibuprofen—ABCC4—tendon—systemic scleroderma	0.00026	0.00562	CbGeAlD
Ibuprofen—SLCO2B1—lung—systemic scleroderma	0.000257	0.00557	CbGeAlD
Ibuprofen—ABCB1—blood vessel—systemic scleroderma	0.000257	0.00556	CbGeAlD
Ibuprofen—PPARG—lung—systemic scleroderma	0.000251	0.00544	CbGeAlD
Ibuprofen—SLCO1A2—lung—systemic scleroderma	0.000237	0.00513	CbGeAlD
Ibuprofen—ABCC4—lung—systemic scleroderma	0.000228	0.00494	CbGeAlD
Ibuprofen—CYP2C19—digestive system—systemic scleroderma	0.000227	0.00492	CbGeAlD
Ibuprofen—PTGS1—connective tissue—systemic scleroderma	0.000222	0.00482	CbGeAlD
Ibuprofen—ABCC1—tendon—systemic scleroderma	0.000221	0.0048	CbGeAlD
Ibuprofen—PTGS2—connective tissue—systemic scleroderma	0.000213	0.0046	CbGeAlD
Ibuprofen—PTGS1—smooth muscle tissue—systemic scleroderma	0.000204	0.00441	CbGeAlD
Ibuprofen—PTGS1—skin of body—systemic scleroderma	0.000201	0.00435	CbGeAlD
Ibuprofen—PTGS2—smooth muscle tissue—systemic scleroderma	0.000195	0.00421	CbGeAlD
Ibuprofen—ABCC1—lung—systemic scleroderma	0.000194	0.00421	CbGeAlD
Ibuprofen—PTGS2—skin of body—systemic scleroderma	0.000192	0.00416	CbGeAlD
Ibuprofen—CYP2C9—digestive system—systemic scleroderma	0.000176	0.00381	CbGeAlD
Ibuprofen—PTGS1—digestive system—systemic scleroderma	0.000161	0.00348	CbGeAlD
Ibuprofen—PTGS2—digestive system—systemic scleroderma	0.000154	0.00333	CbGeAlD
Ibuprofen—PTGS1—tendon—systemic scleroderma	0.000153	0.00331	CbGeAlD
Ibuprofen—PTGS2—tendon—systemic scleroderma	0.000146	0.00317	CbGeAlD
Ibuprofen—PTGS1—lung—systemic scleroderma	0.000134	0.00291	CbGeAlD
Ibuprofen—PTGS2—lung—systemic scleroderma	0.000128	0.00278	CbGeAlD
Ibuprofen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—systemic scleroderma	0.000104	0.00233	CbGpPWpGaD
Ibuprofen—CYP2C19—Melatonin metabolism and effects—EDN1—systemic scleroderma	0.000104	0.00232	CbGpPWpGaD
Ibuprofen—ALB—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	0.000103	0.0023	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—CSK—systemic scleroderma	0.000102	0.00229	CbGpPWpGaD
Ibuprofen—CXCL8—Unfolded Protein Response (UPR)—CCL2—systemic scleroderma	0.000101	0.00226	CbGpPWpGaD
Ibuprofen—ABCC4—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	9.85e-05	0.0022	CbGpPWpGaD
Ibuprofen—BCL2—Interleukin-11 Signaling Pathway—TGFB1—systemic scleroderma	9.79e-05	0.00219	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—SELP—systemic scleroderma	9.75e-05	0.00218	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—ITGAM—systemic scleroderma	9.62e-05	0.00215	CbGpPWpGaD
Ibuprofen—ABCB1—digestive system—systemic scleroderma	9.5e-05	0.00206	CbGeAlD
Ibuprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—systemic scleroderma	9.41e-05	0.00211	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	9.13e-05	0.00204	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—RHOB—systemic scleroderma	9.1e-05	0.00204	CbGpPWpGaD
Ibuprofen—BCL2—IL-3 Signaling Pathway—TGFB1—systemic scleroderma	8.98e-05	0.00201	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	8.98e-05	0.00201	CbGpPWpGaD
Ibuprofen—ABCC4—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	8.97e-05	0.00201	CbGpPWpGaD
Ibuprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	8.89e-05	0.00199	CbGpPWpGaD
Ibuprofen—CXCL8—IL-3 Signaling Pathway—TGFB1—systemic scleroderma	8.63e-05	0.00193	CbGpPWpGaD
Ibuprofen—CXCL8—LPA receptor mediated events—MMP9—systemic scleroderma	8.46e-05	0.00189	CbGpPWpGaD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	8.43e-05	0.00189	CbGpPWpGaD
Ibuprofen—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	8.34e-05	0.00187	CbGpPWpGaD
Ibuprofen—BCL2—Corticotropin-releasing hormone—NOS3—systemic scleroderma	8.2e-05	0.00184	CbGpPWpGaD
Ibuprofen—PLAT—Senescence and Autophagy in Cancer—TGFB1—systemic scleroderma	8.13e-05	0.00182	CbGpPWpGaD
Ibuprofen—THBD—Hemostasis—NOS3—systemic scleroderma	8.03e-05	0.0018	CbGpPWpGaD
Ibuprofen—ABCB1—lung—systemic scleroderma	7.93e-05	0.00172	CbGeAlD
Ibuprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	7.91e-05	0.00177	CbGpPWpGaD
Ibuprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	7.91e-05	0.00177	CbGpPWpGaD
Ibuprofen—CXCL8—Corticotropin-releasing hormone—NOS3—systemic scleroderma	7.88e-05	0.00177	CbGpPWpGaD
Ibuprofen—CXCL8—AP-1 transcription factor network—MMP9—systemic scleroderma	7.87e-05	0.00176	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	7.61e-05	0.00171	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—IL1B—systemic scleroderma	7.58e-05	0.0017	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular Senescence—IL1A—systemic scleroderma	7.33e-05	0.00164	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—CCL2—systemic scleroderma	7.25e-05	0.00162	CbGpPWpGaD
Ibuprofen—CXCL8—Peptide ligand-binding receptors—EDN1—systemic scleroderma	7.24e-05	0.00162	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—IL13—systemic scleroderma	7.17e-05	0.00161	CbGpPWpGaD
Ibuprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	7.17e-05	0.0016	CbGpPWpGaD
Ibuprofen—PPARG—Generic Transcription Pathway—SMAD7—systemic scleroderma	7.15e-05	0.0016	CbGpPWpGaD
Ibuprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic scleroderma	7.07e-05	0.00158	CbGpPWpGaD
Ibuprofen—CXCL8—AP-1 transcription factor network—TGFB1—systemic scleroderma	6.49e-05	0.00145	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	6.36e-05	0.00142	CbGpPWpGaD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—IL1B—systemic scleroderma	6.28e-05	0.00141	CbGpPWpGaD
Ibuprofen—BCL2—Direct p53 effectors—MMP2—systemic scleroderma	6.26e-05	0.0014	CbGpPWpGaD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	6.18e-05	0.00138	CbGpPWpGaD
Ibuprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	6.14e-05	0.00138	CbGpPWpGaD
Ibuprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	6.14e-05	0.00138	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—IL1B—systemic scleroderma	6.04e-05	0.00135	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—TGFB1—systemic scleroderma	5.89e-05	0.00132	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	5.77e-05	0.00129	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular responses to stress—IL1A—systemic scleroderma	5.54e-05	0.00124	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—IL1B—systemic scleroderma	5.5e-05	0.00123	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—SELP—systemic scleroderma	5.44e-05	0.00122	CbGpPWpGaD
Ibuprofen—BCL2—Corticotropin-releasing hormone—TGFB1—systemic scleroderma	5.43e-05	0.00121	CbGpPWpGaD
Ibuprofen—THBD—Hemostasis—TGFB1—systemic scleroderma	5.31e-05	0.00119	CbGpPWpGaD
Ibuprofen—Cough—Mycophenolate mofetil—systemic scleroderma	5.25e-05	0.0004	CcSEcCtD
Ibuprofen—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	5.24e-05	0.00117	CbGpPWpGaD
Ibuprofen—Hypotension—Lisinopril—systemic scleroderma	5.24e-05	0.000399	CcSEcCtD
Ibuprofen—Dizziness—Captopril—systemic scleroderma	5.24e-05	0.000398	CcSEcCtD
Ibuprofen—Liver function test abnormal—Methotrexate—systemic scleroderma	5.23e-05	0.000398	CcSEcCtD
Ibuprofen—Convulsion—Mycophenolate mofetil—systemic scleroderma	5.22e-05	0.000397	CcSEcCtD
Ibuprofen—CXCL8—Corticotropin-releasing hormone—TGFB1—systemic scleroderma	5.21e-05	0.00117	CbGpPWpGaD
Ibuprofen—Depression—Prednisone—systemic scleroderma	5.21e-05	0.000396	CcSEcCtD
Ibuprofen—PPARG—Developmental Biology—RHOB—systemic scleroderma	5.2e-05	0.00117	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—CD247—systemic scleroderma	5.2e-05	0.00116	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—ITGAM—systemic scleroderma	5.2e-05	0.00116	CbGpPWpGaD
Ibuprofen—Hypertension—Mycophenolate mofetil—systemic scleroderma	5.2e-05	0.000396	CcSEcCtD
Ibuprofen—Urticaria—Leflunomide—systemic scleroderma	5.18e-05	0.000395	CcSEcCtD
Ibuprofen—CXCL8—Spinal Cord Injury—MMP9—systemic scleroderma	5.18e-05	0.00116	CbGpPWpGaD
Ibuprofen—Abdominal pain—Leflunomide—systemic scleroderma	5.16e-05	0.000393	CcSEcCtD
Ibuprofen—Acute coronary syndrome—Prednisone—systemic scleroderma	5.15e-05	0.000392	CcSEcCtD
Ibuprofen—Feeling abnormal—Mycophenolic acid—systemic scleroderma	5.13e-05	0.00039	CcSEcCtD
Ibuprofen—Myalgia—Mycophenolate mofetil—systemic scleroderma	5.13e-05	0.00039	CcSEcCtD
Ibuprofen—Arthralgia—Mycophenolate mofetil—systemic scleroderma	5.13e-05	0.00039	CcSEcCtD
Ibuprofen—Myocardial infarction—Prednisone—systemic scleroderma	5.12e-05	0.00039	CcSEcCtD
Ibuprofen—Neuropathy peripheral—Prednisone—systemic scleroderma	5.12e-05	0.00039	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	5.11e-05	0.000389	CcSEcCtD
Ibuprofen—Anxiety—Mycophenolate mofetil—systemic scleroderma	5.11e-05	0.000389	CcSEcCtD
Ibuprofen—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	5.1e-05	0.000388	CcSEcCtD
Ibuprofen—Hypersensitivity—Azathioprine—systemic scleroderma	5.09e-05	0.000387	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	5.09e-05	0.000387	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	5.09e-05	0.000387	CcSEcCtD
Ibuprofen—ABCC4—Hemostasis—RHOB—systemic scleroderma	5.08e-05	0.00114	CbGpPWpGaD
Ibuprofen—Insomnia—Lisinopril—systemic scleroderma	5.07e-05	0.000386	CcSEcCtD
Ibuprofen—Discomfort—Mycophenolate mofetil—systemic scleroderma	5.06e-05	0.000385	CcSEcCtD
Ibuprofen—PTGS1—Selenium Micronutrient Network—CCL2—systemic scleroderma	5.06e-05	0.00113	CbGpPWpGaD
Ibuprofen—Paraesthesia—Lisinopril—systemic scleroderma	5.04e-05	0.000383	CcSEcCtD
Ibuprofen—Vomiting—Captopril—systemic scleroderma	5.03e-05	0.000383	CcSEcCtD
Ibuprofen—ALB—Vitamin B12 Metabolism—CCL2—systemic scleroderma	5.03e-05	0.00113	CbGpPWpGaD
Ibuprofen—Dry mouth—Mycophenolate mofetil—systemic scleroderma	5.01e-05	0.000381	CcSEcCtD
Ibuprofen—ABCC4—Ectoderm Differentiation—CCL2—systemic scleroderma	5.01e-05	0.00112	CbGpPWpGaD
Ibuprofen—Dyspnoea—Lisinopril—systemic scleroderma	5e-05	0.00038	CcSEcCtD
Ibuprofen—Rash—Captopril—systemic scleroderma	4.99e-05	0.00038	CcSEcCtD
Ibuprofen—Dermatitis—Captopril—systemic scleroderma	4.99e-05	0.00038	CcSEcCtD
Ibuprofen—Somnolence—Lisinopril—systemic scleroderma	4.99e-05	0.000379	CcSEcCtD
Ibuprofen—Headache—Captopril—systemic scleroderma	4.96e-05	0.000377	CcSEcCtD
Ibuprofen—Confusional state—Mycophenolate mofetil—systemic scleroderma	4.95e-05	0.000377	CcSEcCtD
Ibuprofen—CXCL8—Peptide ligand-binding receptors—CCL2—systemic scleroderma	4.95e-05	0.00111	CbGpPWpGaD
Ibuprofen—Dyspepsia—Lisinopril—systemic scleroderma	4.94e-05	0.000376	CcSEcCtD
Ibuprofen—PLAT—Signaling Pathways—SMAD7—systemic scleroderma	4.92e-05	0.0011	CbGpPWpGaD
Ibuprofen—Abdominal pain—Mycophenolic acid—systemic scleroderma	4.92e-05	0.000375	CcSEcCtD
Ibuprofen—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	4.91e-05	0.000374	CcSEcCtD
Ibuprofen—Oedema—Mycophenolate mofetil—systemic scleroderma	4.91e-05	0.000374	CcSEcCtD
Ibuprofen—Asthma—Methotrexate—systemic scleroderma	4.89e-05	0.000372	CcSEcCtD
Ibuprofen—Infection—Mycophenolate mofetil—systemic scleroderma	4.88e-05	0.000371	CcSEcCtD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—TGFB1—systemic scleroderma	4.88e-05	0.00109	CbGpPWpGaD
Ibuprofen—Decreased appetite—Lisinopril—systemic scleroderma	4.87e-05	0.000371	CcSEcCtD
Ibuprofen—BCL2—Innate Immune System—TNFAIP3—systemic scleroderma	4.87e-05	0.00109	CbGpPWpGaD
Ibuprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	4.86e-05	0.00109	CbGpPWpGaD
Ibuprofen—Eosinophilia—Methotrexate—systemic scleroderma	4.85e-05	0.000369	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Lisinopril—systemic scleroderma	4.84e-05	0.000368	CcSEcCtD
Ibuprofen—Fatigue—Lisinopril—systemic scleroderma	4.83e-05	0.000368	CcSEcCtD
Ibuprofen—Shock—Mycophenolate mofetil—systemic scleroderma	4.83e-05	0.000368	CcSEcCtD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	4.82e-05	0.00108	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—MMP1—systemic scleroderma	4.82e-05	0.00108	CbGpPWpGaD
Ibuprofen—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	4.82e-05	0.000367	CcSEcCtD
Ibuprofen—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	4.81e-05	0.000366	CcSEcCtD
Ibuprofen—Hypersensitivity—Leflunomide—systemic scleroderma	4.81e-05	0.000366	CcSEcCtD
Ibuprofen—Pancreatitis—Methotrexate—systemic scleroderma	4.8e-05	0.000365	CcSEcCtD
Ibuprofen—Constipation—Lisinopril—systemic scleroderma	4.8e-05	0.000365	CcSEcCtD
Ibuprofen—Tachycardia—Mycophenolate mofetil—systemic scleroderma	4.8e-05	0.000365	CcSEcCtD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	4.77e-05	0.00107	CbGpPWpGaD
Ibuprofen—Skin disorder—Mycophenolate mofetil—systemic scleroderma	4.77e-05	0.000363	CcSEcCtD
Ibuprofen—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	4.75e-05	0.00106	CbGpPWpGaD
Ibuprofen—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	4.75e-05	0.000361	CcSEcCtD
Ibuprofen—BCL2—DNA Damage Response (only ATM dependent)—TGFB1—systemic scleroderma	4.74e-05	0.00106	CbGpPWpGaD
Ibuprofen—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic scleroderma	4.74e-05	0.00106	CbGpPWpGaD
Ibuprofen—Diarrhoea—Azathioprine—systemic scleroderma	4.73e-05	0.00036	CcSEcCtD
Ibuprofen—Haemoglobin—Prednisone—systemic scleroderma	4.71e-05	0.000359	CcSEcCtD
Ibuprofen—Nausea—Captopril—systemic scleroderma	4.7e-05	0.000358	CcSEcCtD
Ibuprofen—Abdominal discomfort—Methotrexate—systemic scleroderma	4.69e-05	0.000357	CcSEcCtD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—TGFB1—systemic scleroderma	4.69e-05	0.00105	CbGpPWpGaD
Ibuprofen—Haemorrhage—Prednisone—systemic scleroderma	4.69e-05	0.000357	CcSEcCtD
Ibuprofen—Anorexia—Mycophenolate mofetil—systemic scleroderma	4.68e-05	0.000356	CcSEcCtD
Ibuprofen—Asthenia—Leflunomide—systemic scleroderma	4.68e-05	0.000356	CcSEcCtD
Ibuprofen—Hallucination—Prednisone—systemic scleroderma	4.66e-05	0.000355	CcSEcCtD
Ibuprofen—Pancytopenia—Methotrexate—systemic scleroderma	4.65e-05	0.000354	CcSEcCtD
Ibuprofen—ABCC4—Hemostasis—CSK—systemic scleroderma	4.62e-05	0.00104	CbGpPWpGaD
Ibuprofen—Feeling abnormal—Lisinopril—systemic scleroderma	4.62e-05	0.000352	CcSEcCtD
Ibuprofen—PTGS2—Spinal Cord Injury—IL1A—systemic scleroderma	4.62e-05	0.00103	CbGpPWpGaD
Ibuprofen—Pruritus—Leflunomide—systemic scleroderma	4.62e-05	0.000351	CcSEcCtD
Ibuprofen—Hypotension—Mycophenolate mofetil—systemic scleroderma	4.59e-05	0.000349	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Lisinopril—systemic scleroderma	4.59e-05	0.000349	CcSEcCtD
Ibuprofen—Neutropenia—Methotrexate—systemic scleroderma	4.58e-05	0.000348	CcSEcCtD
Ibuprofen—Dysuria—Methotrexate—systemic scleroderma	4.58e-05	0.000348	CcSEcCtD
Ibuprofen—Dizziness—Azathioprine—systemic scleroderma	4.57e-05	0.000348	CcSEcCtD
Ibuprofen—ABCC4—Platelet degranulation—TGFB1—systemic scleroderma	4.57e-05	0.00102	CbGpPWpGaD
Ibuprofen—UGT2B4—Metabolism—HSPG2—systemic scleroderma	4.53e-05	0.00101	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	4.51e-05	0.00101	CbGpPWpGaD
Ibuprofen—Erectile dysfunction—Methotrexate—systemic scleroderma	4.51e-05	0.000343	CcSEcCtD
Ibuprofen—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	4.49e-05	0.001	CbGpPWpGaD
Ibuprofen—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	4.48e-05	0.000341	CcSEcCtD
Ibuprofen—Photosensitivity reaction—Methotrexate—systemic scleroderma	4.47e-05	0.00034	CcSEcCtD
Ibuprofen—Asthenia—Mycophenolic acid—systemic scleroderma	4.47e-05	0.00034	CcSEcCtD
Ibuprofen—Diarrhoea—Leflunomide—systemic scleroderma	4.47e-05	0.00034	CcSEcCtD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	4.46e-05	0.000998	CbGpPWpGaD
Ibuprofen—Urticaria—Lisinopril—systemic scleroderma	4.45e-05	0.000339	CcSEcCtD
Ibuprofen—Insomnia—Mycophenolate mofetil—systemic scleroderma	4.44e-05	0.000338	CcSEcCtD
Ibuprofen—Abdominal pain—Lisinopril—systemic scleroderma	4.43e-05	0.000337	CcSEcCtD
Ibuprofen—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	4.41e-05	0.000336	CcSEcCtD
Ibuprofen—Pruritus—Mycophenolic acid—systemic scleroderma	4.4e-05	0.000335	CcSEcCtD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	4.4e-05	0.000985	CbGpPWpGaD
Ibuprofen—Vomiting—Azathioprine—systemic scleroderma	4.39e-05	0.000334	CcSEcCtD
Ibuprofen—Pneumonia—Methotrexate—systemic scleroderma	4.39e-05	0.000334	CcSEcCtD
Ibuprofen—PPARG—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	4.38e-05	0.000981	CbGpPWpGaD
Ibuprofen—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	4.38e-05	0.000333	CcSEcCtD
Ibuprofen—Somnolence—Mycophenolate mofetil—systemic scleroderma	4.37e-05	0.000332	CcSEcCtD
Ibuprofen—Drowsiness—Methotrexate—systemic scleroderma	4.36e-05	0.000332	CcSEcCtD
Ibuprofen—Rash—Azathioprine—systemic scleroderma	4.36e-05	0.000332	CcSEcCtD
Ibuprofen—Dermatitis—Azathioprine—systemic scleroderma	4.35e-05	0.000331	CcSEcCtD
Ibuprofen—Depression—Methotrexate—systemic scleroderma	4.35e-05	0.000331	CcSEcCtD
Ibuprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	4.35e-05	0.000974	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—ITGAM—systemic scleroderma	4.35e-05	0.000973	CbGpPWpGaD
Ibuprofen—Headache—Azathioprine—systemic scleroderma	4.33e-05	0.000329	CcSEcCtD
Ibuprofen—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	4.33e-05	0.000329	CcSEcCtD
Ibuprofen—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	4.33e-05	0.000329	CcSEcCtD
Ibuprofen—Dizziness—Leflunomide—systemic scleroderma	4.32e-05	0.000328	CcSEcCtD
Ibuprofen—Renal failure—Methotrexate—systemic scleroderma	4.29e-05	0.000326	CcSEcCtD
Ibuprofen—CXCL8—Spinal Cord Injury—TGFB1—systemic scleroderma	4.27e-05	0.000957	CbGpPWpGaD
Ibuprofen—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	4.27e-05	0.000325	CcSEcCtD
Ibuprofen—Diarrhoea—Mycophenolic acid—systemic scleroderma	4.26e-05	0.000324	CcSEcCtD
Ibuprofen—Stomatitis—Methotrexate—systemic scleroderma	4.25e-05	0.000324	CcSEcCtD
Ibuprofen—Conjunctivitis—Methotrexate—systemic scleroderma	4.24e-05	0.000323	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	4.24e-05	0.000323	CcSEcCtD
Ibuprofen—Immune system disorder—Prednisone—systemic scleroderma	4.23e-05	0.000322	CcSEcCtD
Ibuprofen—Constipation—Mycophenolate mofetil—systemic scleroderma	4.2e-05	0.00032	CcSEcCtD
Ibuprofen—Arrhythmia—Prednisone—systemic scleroderma	4.19e-05	0.000319	CcSEcCtD
Ibuprofen—Sweating—Methotrexate—systemic scleroderma	4.18e-05	0.000318	CcSEcCtD
Ibuprofen—Haematuria—Methotrexate—systemic scleroderma	4.16e-05	0.000317	CcSEcCtD
Ibuprofen—Vomiting—Leflunomide—systemic scleroderma	4.15e-05	0.000316	CcSEcCtD
Ibuprofen—Alopecia—Prednisone—systemic scleroderma	4.14e-05	0.000315	CcSEcCtD
Ibuprofen—Hypersensitivity—Lisinopril—systemic scleroderma	4.13e-05	0.000314	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Methotrexate—systemic scleroderma	4.13e-05	0.000314	CcSEcCtD
Ibuprofen—Dizziness—Mycophenolic acid—systemic scleroderma	4.12e-05	0.000313	CcSEcCtD
Ibuprofen—Epistaxis—Methotrexate—systemic scleroderma	4.12e-05	0.000313	CcSEcCtD
Ibuprofen—Rash—Leflunomide—systemic scleroderma	4.11e-05	0.000313	CcSEcCtD
Ibuprofen—Dermatitis—Leflunomide—systemic scleroderma	4.11e-05	0.000313	CcSEcCtD
Ibuprofen—Mental disorder—Prednisone—systemic scleroderma	4.11e-05	0.000313	CcSEcCtD
Ibuprofen—Nausea—Azathioprine—systemic scleroderma	4.1e-05	0.000312	CcSEcCtD
Ibuprofen—CXCL8—GPCR downstream signaling—RHOB—systemic scleroderma	4.1e-05	0.000917	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—CCL2—systemic scleroderma	4.09e-05	0.000916	CbGpPWpGaD
Ibuprofen—Headache—Leflunomide—systemic scleroderma	4.09e-05	0.000311	CcSEcCtD
Ibuprofen—Malnutrition—Prednisone—systemic scleroderma	4.08e-05	0.000311	CcSEcCtD
Ibuprofen—Erythema—Prednisone—systemic scleroderma	4.08e-05	0.000311	CcSEcCtD
Ibuprofen—Agranulocytosis—Methotrexate—systemic scleroderma	4.07e-05	0.00031	CcSEcCtD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	4.06e-05	0.000909	CbGpPWpGaD
Ibuprofen—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	4.05e-05	0.000308	CcSEcCtD
Ibuprofen—SLCO1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	4.04e-05	0.000904	CbGpPWpGaD
Ibuprofen—Asthenia—Lisinopril—systemic scleroderma	4.02e-05	0.000306	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	4.02e-05	0.000306	CcSEcCtD
Ibuprofen—PTGS2—Selenium Micronutrient Network—CCL2—systemic scleroderma	4.02e-05	0.000899	CbGpPWpGaD
Ibuprofen—Pruritus—Lisinopril—systemic scleroderma	3.97e-05	0.000302	CcSEcCtD
Ibuprofen—Vomiting—Mycophenolic acid—systemic scleroderma	3.96e-05	0.000301	CcSEcCtD
Ibuprofen—PPARG—Generic Transcription Pathway—CTGF—systemic scleroderma	3.95e-05	0.000885	CbGpPWpGaD
Ibuprofen—Haemoglobin—Methotrexate—systemic scleroderma	3.94e-05	0.0003	CcSEcCtD
Ibuprofen—Rash—Mycophenolic acid—systemic scleroderma	3.93e-05	0.000299	CcSEcCtD
Ibuprofen—Dermatitis—Mycophenolic acid—systemic scleroderma	3.92e-05	0.000298	CcSEcCtD
Ibuprofen—Haemorrhage—Methotrexate—systemic scleroderma	3.92e-05	0.000298	CcSEcCtD
Ibuprofen—Hepatitis—Methotrexate—systemic scleroderma	3.92e-05	0.000298	CcSEcCtD
Ibuprofen—Urticaria—Mycophenolate mofetil—systemic scleroderma	3.9e-05	0.000297	CcSEcCtD
Ibuprofen—Headache—Mycophenolic acid—systemic scleroderma	3.9e-05	0.000297	CcSEcCtD
Ibuprofen—Pharyngitis—Methotrexate—systemic scleroderma	3.89e-05	0.000296	CcSEcCtD
Ibuprofen—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	3.88e-05	0.000296	CcSEcCtD
Ibuprofen—Nausea—Leflunomide—systemic scleroderma	3.88e-05	0.000295	CcSEcCtD
Ibuprofen—Urinary tract disorder—Methotrexate—systemic scleroderma	3.87e-05	0.000294	CcSEcCtD
Ibuprofen—Vision blurred—Prednisone—systemic scleroderma	3.85e-05	0.000293	CcSEcCtD
Ibuprofen—Urethral disorder—Methotrexate—systemic scleroderma	3.84e-05	0.000292	CcSEcCtD
Ibuprofen—Diarrhoea—Lisinopril—systemic scleroderma	3.84e-05	0.000292	CcSEcCtD
Ibuprofen—PTGS1—Selenium Micronutrient Network—IL1B—systemic scleroderma	3.84e-05	0.000859	CbGpPWpGaD
Ibuprofen—ALB—Vitamin B12 Metabolism—IL1B—systemic scleroderma	3.81e-05	0.000854	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—RHOB—systemic scleroderma	3.81e-05	0.000853	CbGpPWpGaD
Ibuprofen—Ill-defined disorder—Prednisone—systemic scleroderma	3.79e-05	0.000288	CcSEcCtD
Ibuprofen—Visual impairment—Methotrexate—systemic scleroderma	3.78e-05	0.000287	CcSEcCtD
Ibuprofen—Anaemia—Prednisone—systemic scleroderma	3.77e-05	0.000287	CcSEcCtD
Ibuprofen—UGT1A9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.77e-05	0.000843	CbGpPWpGaD
Ibuprofen—Agitation—Prednisone—systemic scleroderma	3.75e-05	0.000285	CcSEcCtD
Ibuprofen—Angioedema—Prednisone—systemic scleroderma	3.73e-05	0.000284	CcSEcCtD
Ibuprofen—CXCL8—Signaling by GPCR—RHOB—systemic scleroderma	3.72e-05	0.000833	CbGpPWpGaD
Ibuprofen—Dizziness—Lisinopril—systemic scleroderma	3.71e-05	0.000282	CcSEcCtD
Ibuprofen—Erythema multiforme—Methotrexate—systemic scleroderma	3.7e-05	0.000282	CcSEcCtD
Ibuprofen—CXCL8—GPCR ligand binding—EDN1—systemic scleroderma	3.7e-05	0.000829	CbGpPWpGaD
Ibuprofen—Nausea—Mycophenolic acid—systemic scleroderma	3.7e-05	0.000281	CcSEcCtD
Ibuprofen—Malaise—Prednisone—systemic scleroderma	3.68e-05	0.00028	CcSEcCtD
Ibuprofen—Vertigo—Prednisone—systemic scleroderma	3.67e-05	0.000279	CcSEcCtD
Ibuprofen—Syncope—Prednisone—systemic scleroderma	3.66e-05	0.000278	CcSEcCtD
Ibuprofen—Tinnitus—Methotrexate—systemic scleroderma	3.65e-05	0.000278	CcSEcCtD
Ibuprofen—ABCC1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.63e-05	0.000813	CbGpPWpGaD
Ibuprofen—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	3.62e-05	0.000275	CcSEcCtD
Ibuprofen—PLAT—Signaling Pathways—HSPG2—systemic scleroderma	3.59e-05	0.000804	CbGpPWpGaD
Ibuprofen—Loss of consciousness—Prednisone—systemic scleroderma	3.59e-05	0.000273	CcSEcCtD
Ibuprofen—Vomiting—Lisinopril—systemic scleroderma	3.57e-05	0.000271	CcSEcCtD
Ibuprofen—Immune system disorder—Methotrexate—systemic scleroderma	3.54e-05	0.000269	CcSEcCtD
Ibuprofen—Rash—Lisinopril—systemic scleroderma	3.54e-05	0.000269	CcSEcCtD
Ibuprofen—Convulsion—Prednisone—systemic scleroderma	3.54e-05	0.000269	CcSEcCtD
Ibuprofen—Dermatitis—Lisinopril—systemic scleroderma	3.53e-05	0.000269	CcSEcCtD
Ibuprofen—Mediastinal disorder—Methotrexate—systemic scleroderma	3.53e-05	0.000269	CcSEcCtD
Ibuprofen—UGT1A3—NRF2 pathway—TGFB1—systemic scleroderma	3.53e-05	0.00079	CbGpPWpGaD
Ibuprofen—Asthenia—Mycophenolate mofetil—systemic scleroderma	3.53e-05	0.000268	CcSEcCtD
Ibuprofen—Hypertension—Prednisone—systemic scleroderma	3.52e-05	0.000268	CcSEcCtD
Ibuprofen—Chills—Methotrexate—systemic scleroderma	3.52e-05	0.000268	CcSEcCtD
Ibuprofen—Headache—Lisinopril—systemic scleroderma	3.51e-05	0.000267	CcSEcCtD
Ibuprofen—PLAT—Hemostasis—NOS3—systemic scleroderma	3.5e-05	0.000783	CbGpPWpGaD
Ibuprofen—Pruritus—Mycophenolate mofetil—systemic scleroderma	3.48e-05	0.000265	CcSEcCtD
Ibuprofen—Arthralgia—Prednisone—systemic scleroderma	3.47e-05	0.000264	CcSEcCtD
Ibuprofen—Myalgia—Prednisone—systemic scleroderma	3.47e-05	0.000264	CcSEcCtD
Ibuprofen—PLAT—Signaling Pathways—CSK—systemic scleroderma	3.47e-05	0.000777	CbGpPWpGaD
Ibuprofen—Anxiety—Prednisone—systemic scleroderma	3.46e-05	0.000263	CcSEcCtD
Ibuprofen—Alopecia—Methotrexate—systemic scleroderma	3.46e-05	0.000263	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	3.45e-05	0.000263	CcSEcCtD
Ibuprofen—PPARG—Gene Expression—SMAD7—systemic scleroderma	3.44e-05	0.000771	CbGpPWpGaD
Ibuprofen—UGT2B4—Metabolism—CTGF—systemic scleroderma	3.43e-05	0.000769	CbGpPWpGaD
Ibuprofen—Discomfort—Prednisone—systemic scleroderma	3.43e-05	0.000261	CcSEcCtD
Ibuprofen—Mental disorder—Methotrexate—systemic scleroderma	3.43e-05	0.000261	CcSEcCtD
Ibuprofen—Malnutrition—Methotrexate—systemic scleroderma	3.41e-05	0.00026	CcSEcCtD
Ibuprofen—Erythema—Methotrexate—systemic scleroderma	3.41e-05	0.00026	CcSEcCtD
Ibuprofen—CXCL8—Metabolism of proteins—ACE—systemic scleroderma	3.41e-05	0.000763	CbGpPWpGaD
Ibuprofen—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	3.36e-05	0.000256	CcSEcCtD
Ibuprofen—Dysgeusia—Methotrexate—systemic scleroderma	3.34e-05	0.000254	CcSEcCtD
Ibuprofen—Nausea—Lisinopril—systemic scleroderma	3.33e-05	0.000253	CcSEcCtD
Ibuprofen—Oedema—Prednisone—systemic scleroderma	3.33e-05	0.000253	CcSEcCtD
Ibuprofen—Anaphylactic shock—Prednisone—systemic scleroderma	3.33e-05	0.000253	CcSEcCtD
Ibuprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	3.32e-05	0.000744	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.32e-05	0.000744	CbGpPWpGaD
Ibuprofen—Infection—Prednisone—systemic scleroderma	3.31e-05	0.000252	CcSEcCtD
Ibuprofen—Shock—Prednisone—systemic scleroderma	3.28e-05	0.000249	CcSEcCtD
Ibuprofen—Nervous system disorder—Prednisone—systemic scleroderma	3.27e-05	0.000249	CcSEcCtD
Ibuprofen—Tachycardia—Prednisone—systemic scleroderma	3.25e-05	0.000247	CcSEcCtD
Ibuprofen—Dizziness—Mycophenolate mofetil—systemic scleroderma	3.25e-05	0.000247	CcSEcCtD
Ibuprofen—ALB—Selenium Micronutrient Network—CCL2—systemic scleroderma	3.25e-05	0.000727	CbGpPWpGaD
Ibuprofen—Skin disorder—Prednisone—systemic scleroderma	3.24e-05	0.000246	CcSEcCtD
Ibuprofen—BCL2—Immune System—CSK—systemic scleroderma	3.22e-05	0.000721	CbGpPWpGaD
Ibuprofen—Hyperhidrosis—Prednisone—systemic scleroderma	3.22e-05	0.000245	CcSEcCtD
Ibuprofen—Vision blurred—Methotrexate—systemic scleroderma	3.21e-05	0.000245	CcSEcCtD
Ibuprofen—PPARG—Gene Expression—TNFSF13—systemic scleroderma	3.2e-05	0.000716	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—CCL2—systemic scleroderma	3.18e-05	0.000711	CbGpPWpGaD
Ibuprofen—Anorexia—Prednisone—systemic scleroderma	3.17e-05	0.000242	CcSEcCtD
Ibuprofen—BCL2—Immune System—IRF5—systemic scleroderma	3.17e-05	0.00071	CbGpPWpGaD
Ibuprofen—Ill-defined disorder—Methotrexate—systemic scleroderma	3.16e-05	0.000241	CcSEcCtD
Ibuprofen—Anaemia—Methotrexate—systemic scleroderma	3.15e-05	0.00024	CcSEcCtD
Ibuprofen—Vomiting—Mycophenolate mofetil—systemic scleroderma	3.12e-05	0.000238	CcSEcCtD
Ibuprofen—PPARG—Adipogenesis—TGFB1—systemic scleroderma	3.11e-05	0.000697	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—IL1B—systemic scleroderma	3.1e-05	0.000695	CbGpPWpGaD
Ibuprofen—Rash—Mycophenolate mofetil—systemic scleroderma	3.1e-05	0.000236	CcSEcCtD
Ibuprofen—Dermatitis—Mycophenolate mofetil—systemic scleroderma	3.1e-05	0.000236	CcSEcCtD
Ibuprofen—Headache—Mycophenolate mofetil—systemic scleroderma	3.08e-05	0.000234	CcSEcCtD
Ibuprofen—Malaise—Methotrexate—systemic scleroderma	3.08e-05	0.000234	CcSEcCtD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.07e-05	0.000688	CbGpPWpGaD
Ibuprofen—Vertigo—Methotrexate—systemic scleroderma	3.06e-05	0.000233	CcSEcCtD
Ibuprofen—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.06e-05	0.000685	CbGpPWpGaD
Ibuprofen—Leukopenia—Methotrexate—systemic scleroderma	3.05e-05	0.000232	CcSEcCtD
Ibuprofen—PTGS2—Selenium Micronutrient Network—IL1B—systemic scleroderma	3.05e-05	0.000682	CbGpPWpGaD
Ibuprofen—Musculoskeletal discomfort—Prednisone—systemic scleroderma	3.03e-05	0.000231	CcSEcCtD
Ibuprofen—BCL2—Immune System—CD247—systemic scleroderma	3.03e-05	0.000678	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IRF8—systemic scleroderma	3.03e-05	0.000678	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—ITGAM—systemic scleroderma	3.03e-05	0.000678	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	3.02e-05	0.000677	CbGpPWpGaD
Ibuprofen—Insomnia—Prednisone—systemic scleroderma	3.01e-05	0.000229	CcSEcCtD
Ibuprofen—UGT2B7—NRF2 pathway—TGFB1—systemic scleroderma	3e-05	0.000672	CbGpPWpGaD
Ibuprofen—Paraesthesia—Prednisone—systemic scleroderma	2.99e-05	0.000228	CcSEcCtD
Ibuprofen—Cough—Methotrexate—systemic scleroderma	2.98e-05	0.000226	CcSEcCtD
Ibuprofen—Convulsion—Methotrexate—systemic scleroderma	2.95e-05	0.000225	CcSEcCtD
Ibuprofen—Dyspepsia—Prednisone—systemic scleroderma	2.93e-05	0.000223	CcSEcCtD
Ibuprofen—Nausea—Mycophenolate mofetil—systemic scleroderma	2.92e-05	0.000222	CcSEcCtD
Ibuprofen—Myalgia—Methotrexate—systemic scleroderma	2.9e-05	0.000221	CcSEcCtD
Ibuprofen—Arthralgia—Methotrexate—systemic scleroderma	2.9e-05	0.000221	CcSEcCtD
Ibuprofen—Decreased appetite—Prednisone—systemic scleroderma	2.9e-05	0.00022	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	2.88e-05	0.000219	CcSEcCtD
Ibuprofen—Fatigue—Prednisone—systemic scleroderma	2.87e-05	0.000219	CcSEcCtD
Ibuprofen—Discomfort—Methotrexate—systemic scleroderma	2.87e-05	0.000218	CcSEcCtD
Ibuprofen—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.85e-05	0.000639	CbGpPWpGaD
Ibuprofen—Constipation—Prednisone—systemic scleroderma	2.85e-05	0.000217	CcSEcCtD
Ibuprofen—CXCL8—Signaling Pathways—SMAD7—systemic scleroderma	2.84e-05	0.000636	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—TNFAIP3—systemic scleroderma	2.84e-05	0.000635	CbGpPWpGaD
Ibuprofen—ABCC4—NRF2 pathway—TGFB1—systemic scleroderma	2.82e-05	0.000632	CbGpPWpGaD
Ibuprofen—Confusional state—Methotrexate—systemic scleroderma	2.81e-05	0.000214	CcSEcCtD
Ibuprofen—BCL2—Immune System—BLK—systemic scleroderma	2.8e-05	0.000627	CbGpPWpGaD
Ibuprofen—Anaphylactic shock—Methotrexate—systemic scleroderma	2.78e-05	0.000212	CcSEcCtD
Ibuprofen—Infection—Methotrexate—systemic scleroderma	2.77e-05	0.00021	CcSEcCtD
Ibuprofen—ABCC1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.75e-05	0.000616	CbGpPWpGaD
Ibuprofen—Feeling abnormal—Prednisone—systemic scleroderma	2.74e-05	0.000209	CcSEcCtD
Ibuprofen—Nervous system disorder—Methotrexate—systemic scleroderma	2.73e-05	0.000208	CcSEcCtD
Ibuprofen—Thrombocytopenia—Methotrexate—systemic scleroderma	2.73e-05	0.000207	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Prednisone—systemic scleroderma	2.72e-05	0.000207	CcSEcCtD
Ibuprofen—Skin disorder—Methotrexate—systemic scleroderma	2.7e-05	0.000206	CcSEcCtD
Ibuprofen—Hyperhidrosis—Methotrexate—systemic scleroderma	2.69e-05	0.000205	CcSEcCtD
Ibuprofen—Anorexia—Methotrexate—systemic scleroderma	2.65e-05	0.000202	CcSEcCtD
Ibuprofen—ABCC1—Disease—SMAD7—systemic scleroderma	2.65e-05	0.000593	CbGpPWpGaD
Ibuprofen—Urticaria—Prednisone—systemic scleroderma	2.65e-05	0.000201	CcSEcCtD
Ibuprofen—Abdominal pain—Prednisone—systemic scleroderma	2.63e-05	0.0002	CcSEcCtD
Ibuprofen—Hypotension—Methotrexate—systemic scleroderma	2.6e-05	0.000198	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	2.54e-05	0.000193	CcSEcCtD
Ibuprofen—CXCL8—GPCR ligand binding—CCL2—systemic scleroderma	2.53e-05	0.000566	CbGpPWpGaD
Ibuprofen—Insomnia—Methotrexate—systemic scleroderma	2.52e-05	0.000192	CcSEcCtD
Ibuprofen—Paraesthesia—Methotrexate—systemic scleroderma	2.5e-05	0.00019	CcSEcCtD
Ibuprofen—Dyspnoea—Methotrexate—systemic scleroderma	2.48e-05	0.000189	CcSEcCtD
Ibuprofen—Somnolence—Methotrexate—systemic scleroderma	2.47e-05	0.000188	CcSEcCtD
Ibuprofen—ALB—Selenium Micronutrient Network—IL1B—systemic scleroderma	2.46e-05	0.000552	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—SELP—systemic scleroderma	2.46e-05	0.000551	CbGpPWpGaD
Ibuprofen—Hypersensitivity—Prednisone—systemic scleroderma	2.45e-05	0.000187	CcSEcCtD
Ibuprofen—Dyspepsia—Methotrexate—systemic scleroderma	2.45e-05	0.000186	CcSEcCtD
Ibuprofen—UGT1A1—NRF2 pathway—TGFB1—systemic scleroderma	2.44e-05	0.000546	CbGpPWpGaD
Ibuprofen—UGT1A9—NRF2 pathway—TGFB1—systemic scleroderma	2.44e-05	0.000546	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.44e-05	0.000546	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—HSPG2—systemic scleroderma	2.43e-05	0.000544	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—TGFBI—systemic scleroderma	2.42e-05	0.000542	CbGpPWpGaD
Ibuprofen—Decreased appetite—Methotrexate—systemic scleroderma	2.42e-05	0.000184	CcSEcCtD
Ibuprofen—PTGS2—Spinal Cord Injury—IL1B—systemic scleroderma	2.41e-05	0.000539	CbGpPWpGaD
Ibuprofen—Gastrointestinal disorder—Methotrexate—systemic scleroderma	2.4e-05	0.000183	CcSEcCtD
Ibuprofen—Fatigue—Methotrexate—systemic scleroderma	2.4e-05	0.000183	CcSEcCtD
Ibuprofen—Asthenia—Prednisone—systemic scleroderma	2.39e-05	0.000182	CcSEcCtD
Ibuprofen—Pruritus—Prednisone—systemic scleroderma	2.36e-05	0.000179	CcSEcCtD
Ibuprofen—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	2.35e-05	0.000527	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.33e-05	0.000521	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—TGFB1—systemic scleroderma	2.31e-05	0.000518	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—RHOB—systemic scleroderma	2.3e-05	0.000514	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CTLA4—systemic scleroderma	2.29e-05	0.000514	CbGpPWpGaD
Ibuprofen—Feeling abnormal—Methotrexate—systemic scleroderma	2.29e-05	0.000175	CcSEcCtD
Ibuprofen—Diarrhoea—Prednisone—systemic scleroderma	2.28e-05	0.000173	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Methotrexate—systemic scleroderma	2.28e-05	0.000173	CcSEcCtD
Ibuprofen—PTGS2—Spinal Cord Injury—MMP9—systemic scleroderma	2.27e-05	0.000509	CbGpPWpGaD
Ibuprofen—Urticaria—Methotrexate—systemic scleroderma	2.21e-05	0.000168	CcSEcCtD
Ibuprofen—Dizziness—Prednisone—systemic scleroderma	2.2e-05	0.000168	CcSEcCtD
Ibuprofen—Abdominal pain—Methotrexate—systemic scleroderma	2.2e-05	0.000167	CcSEcCtD
Ibuprofen—CXCL8—Signaling Pathways—RHOB—systemic scleroderma	2.2e-05	0.000492	CbGpPWpGaD
Ibuprofen—CXCL8—Metabolism of proteins—MMP1—systemic scleroderma	2.19e-05	0.00049	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—MMP1—systemic scleroderma	2.18e-05	0.000488	CbGpPWpGaD
Ibuprofen—Vomiting—Prednisone—systemic scleroderma	2.12e-05	0.000161	CcSEcCtD
Ibuprofen—Rash—Prednisone—systemic scleroderma	2.1e-05	0.00016	CcSEcCtD
Ibuprofen—Dermatitis—Prednisone—systemic scleroderma	2.1e-05	0.00016	CcSEcCtD
Ibuprofen—ALB—Hemostasis—CSK—systemic scleroderma	2.09e-05	0.000468	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—EDN1—systemic scleroderma	2.09e-05	0.000468	CbGpPWpGaD
Ibuprofen—Headache—Prednisone—systemic scleroderma	2.09e-05	0.000159	CcSEcCtD
Ibuprofen—CXCL8—Signaling Pathways—HSPG2—systemic scleroderma	2.07e-05	0.000464	CbGpPWpGaD
Ibuprofen—ALB—Platelet degranulation—TGFB1—systemic scleroderma	2.07e-05	0.000463	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—HSPG2—systemic scleroderma	2.06e-05	0.000462	CbGpPWpGaD
Ibuprofen—Hypersensitivity—Methotrexate—systemic scleroderma	2.05e-05	0.000156	CcSEcCtD
Ibuprofen—ABCC4—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	2.03e-05	0.000454	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CSK—systemic scleroderma	2e-05	0.000448	CbGpPWpGaD
Ibuprofen—Asthenia—Methotrexate—systemic scleroderma	2e-05	0.000152	CcSEcCtD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.98e-05	0.000444	CbGpPWpGaD
Ibuprofen—Nausea—Prednisone—systemic scleroderma	1.98e-05	0.000151	CcSEcCtD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.97e-05	0.000442	CbGpPWpGaD
Ibuprofen—Pruritus—Methotrexate—systemic scleroderma	1.97e-05	0.00015	CcSEcCtD
Ibuprofen—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	1.97e-05	0.000441	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—ITGAM—systemic scleroderma	1.97e-05	0.00044	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—HSPG2—systemic scleroderma	1.95e-05	0.000437	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—EDN1—systemic scleroderma	1.94e-05	0.000436	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—HSPG2—systemic scleroderma	1.93e-05	0.000432	CbGpPWpGaD
Ibuprofen—Diarrhoea—Methotrexate—systemic scleroderma	1.9e-05	0.000145	CcSEcCtD
Ibuprofen—PPARG—Gene Expression—CTGF—systemic scleroderma	1.9e-05	0.000426	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—EDN1—systemic scleroderma	1.9e-05	0.000425	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HLA-DQB1—systemic scleroderma	1.89e-05	0.000423	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—TGFB1—systemic scleroderma	1.87e-05	0.000419	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CSK—systemic scleroderma	1.87e-05	0.000418	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.85e-05	0.000414	CbGpPWpGaD
Ibuprofen—Dizziness—Methotrexate—systemic scleroderma	1.84e-05	0.00014	CcSEcCtD
Ibuprofen—UGT1A3—Metabolism—CTGF—systemic scleroderma	1.84e-05	0.000412	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	1.83e-05	0.00041	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—HSPG2—systemic scleroderma	1.8e-05	0.000402	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IL1A—systemic scleroderma	1.79e-05	0.000402	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD40LG—systemic scleroderma	1.78e-05	0.0004	CbGpPWpGaD
Ibuprofen—CXCL8—Metabolism of proteins—CCL2—systemic scleroderma	1.78e-05	0.000398	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—SMAD7—systemic scleroderma	1.78e-05	0.000398	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.77e-05	0.000396	CbGpPWpGaD
Ibuprofen—Vomiting—Methotrexate—systemic scleroderma	1.77e-05	0.000135	CcSEcCtD
Ibuprofen—Rash—Methotrexate—systemic scleroderma	1.75e-05	0.000134	CcSEcCtD
Ibuprofen—ABCC1—Disease—CD247—systemic scleroderma	1.75e-05	0.000393	CbGpPWpGaD
Ibuprofen—Dermatitis—Methotrexate—systemic scleroderma	1.75e-05	0.000133	CcSEcCtD
Ibuprofen—Headache—Methotrexate—systemic scleroderma	1.74e-05	0.000133	CcSEcCtD
Ibuprofen—PPARG—Developmental Biology—MMP2—systemic scleroderma	1.73e-05	0.000387	CbGpPWpGaD
Ibuprofen—CXCL8—Metabolism of proteins—MMP2—systemic scleroderma	1.69e-05	0.000379	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—HSPG2—systemic scleroderma	1.68e-05	0.000376	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—HSPG2—systemic scleroderma	1.68e-05	0.000376	CbGpPWpGaD
Ibuprofen—Nausea—Methotrexate—systemic scleroderma	1.65e-05	0.000126	CcSEcCtD
Ibuprofen—PTGS2—Disease—TGFBI—systemic scleroderma	1.62e-05	0.000364	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—HSPG2—systemic scleroderma	1.62e-05	0.000362	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.61e-05	0.000361	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—NOS3—systemic scleroderma	1.58e-05	0.000354	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—CTGF—systemic scleroderma	1.56e-05	0.00035	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.5e-05	0.000337	CbGpPWpGaD
Ibuprofen—UGT2B4—Metabolism—NOS3—systemic scleroderma	1.49e-05	0.000335	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.49e-05	0.000335	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—CTGF—systemic scleroderma	1.48e-05	0.000331	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—HSPG2—systemic scleroderma	1.37e-05	0.000306	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—CTGF—systemic scleroderma	1.36e-05	0.000305	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.34e-05	0.0003	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—CCL2—systemic scleroderma	1.33e-05	0.000298	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—MMP9—systemic scleroderma	1.3e-05	0.000291	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—CCL2—systemic scleroderma	1.3e-05	0.000291	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—HSPG2—systemic scleroderma	1.3e-05	0.00029	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.27e-05	0.000285	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—CTGF—systemic scleroderma	1.27e-05	0.000285	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—CTGF—systemic scleroderma	1.27e-05	0.000285	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CSK—systemic scleroderma	1.25e-05	0.00028	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—CTGF—systemic scleroderma	1.23e-05	0.000274	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.22e-05	0.000274	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—NOS3—systemic scleroderma	1.19e-05	0.000265	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CD247—systemic scleroderma	1.18e-05	0.000264	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—EDN1—systemic scleroderma	1.12e-05	0.000251	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—HSPG2—systemic scleroderma	1.09e-05	0.000243	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—TGFB1—systemic scleroderma	1.07e-05	0.00024	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—TGFB1—systemic scleroderma	1.04e-05	0.000234	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—CTGF—systemic scleroderma	1.04e-05	0.000232	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—MMP1—systemic scleroderma	9.86e-06	0.000221	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—MMP9—systemic scleroderma	9.51e-06	0.000213	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IL1B—systemic scleroderma	9.36e-06	0.00021	CbGpPWpGaD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	9.17e-06	0.000205	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	9.02e-06	0.000202	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—HSPG2—systemic scleroderma	8.83e-06	0.000198	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—HSPG2—systemic scleroderma	8.78e-06	0.000197	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—CTGF—systemic scleroderma	8.23e-06	0.000184	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—NOS3—systemic scleroderma	8.01e-06	0.000179	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—HSPG2—systemic scleroderma	7.88e-06	0.000177	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—TGFB1—systemic scleroderma	7.84e-06	0.000175	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—HSPG2—systemic scleroderma	7.69e-06	0.000172	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CCL2—systemic scleroderma	7.67e-06	0.000172	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—HSPG2—systemic scleroderma	7.19e-06	0.000161	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—NOS3—systemic scleroderma	7.14e-06	0.00016	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—NOS3—systemic scleroderma	6.83e-06	0.000153	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—NOS3—systemic scleroderma	6.81e-06	0.000152	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—CTGF—systemic scleroderma	6.69e-06	0.00015	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—CTGF—systemic scleroderma	6.66e-06	0.000149	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—NOS3—systemic scleroderma	6.44e-06	0.000144	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—NOS3—systemic scleroderma	6.37e-06	0.000143	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—CTGF—systemic scleroderma	5.97e-06	0.000134	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—NOS3—systemic scleroderma	5.93e-06	0.000133	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—CTGF—systemic scleroderma	5.83e-06	0.000131	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—NOS3—systemic scleroderma	5.53e-06	0.000124	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—NOS3—systemic scleroderma	5.53e-06	0.000124	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MMP9—systemic scleroderma	5.48e-06	0.000123	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CTGF—systemic scleroderma	5.45e-06	0.000122	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—NOS3—systemic scleroderma	5.34e-06	0.000119	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—TGFB1—systemic scleroderma	4.72e-06	0.000106	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—TGFB1—systemic scleroderma	4.52e-06	0.000101	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—NOS3—systemic scleroderma	4.51e-06	0.000101	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—NOS3—systemic scleroderma	4.28e-06	9.57e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—TGFB1—systemic scleroderma	4.21e-06	9.43e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—NOS3—systemic scleroderma	3.58e-06	8.02e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—NOS3—systemic scleroderma	2.91e-06	6.52e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—NOS3—systemic scleroderma	2.9e-06	6.49e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—TGFB1—systemic scleroderma	2.83e-06	6.33e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—NOS3—systemic scleroderma	2.6e-06	5.82e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—NOS3—systemic scleroderma	2.54e-06	5.68e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—NOS3—systemic scleroderma	2.37e-06	5.31e-05	CbGpPWpGaD
